Exane Derivatives

SEC CIK: 0001623883
Latest filing: Jul 12, 2022

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q2 2022 holdings

Shares (Q2 2021): 0; Sold out in Q2 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2021

Holdings of APLS by Exane Derivatives, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	0	$0	0.0%	−1,589−100.0%	Sold out	Holders
Q1 2021	1,589	$68.2K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.